HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 120 filers reported holding HOMOLOGY MEDICINES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,000 | -18.2% | 3,003 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -54.2% | 3,003 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $24,000 | +9.1% | 3,003 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $22,000 | -21.4% | 3,003 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $28,000 | -17.6% | 3,003 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $34,000 | +6.2% | 3,003 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $32,000 | -30.4% | 3,003 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $46,000 | +43.8% | 3,003 | +43.8% | 0.00% | 0.0% |
| Q1 2020 | $32,000 | -25.6% | 2,088 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $43,000 | +13.2% | 2,088 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $38,000 | -7.3% | 2,088 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $41,000 | +5.1% | 2,088 | +46.6% | 0.00% | 0.0% |
| Q1 2019 | $39,000 | +105.3% | 1,424 | +64.8% | 0.00% | +100.0% |
| Q4 2018 | $19,000 | -5.0% | 864 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $20,000 | +11.1% | 864 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $18,000 | – | 864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $13,789,000 | 3.01% |
| Vida Ventures Advisors, LLC | 770,845 | $2,343,000 | 1.36% |
| Vivo Capital, LLC | 853,143 | $2,594,000 | 0.18% |
| OUP Management Co., LLC | 64,000 | $195,000 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 214,898 | $653,000 | 0.13% |
| AAF Wealth Management, LLC | 47,501 | $144,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 228,365 | $694,000 | 0.09% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $17,179,028 | 0.07% |
| Bellevue Group AG | 1,647,122 | $5,007,000 | 0.06% |
| Virtus ETF Advisers LLC | 35,487 | $108,000 | 0.05% |